Unnecessary use of steroid leads to risk of severe fungal infections: Doctors
Pune: After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…
UP has emerged as India’s largest Healthcare & med tech hub: Yogi
Lucknow: Chief Minister Yogi Adityanath on Sunday said that Uttar Pradesh is not merely a state with a population of 25 crore but has also emerged as the country’s largest hub…
Over 9,000 deaths due to respiratory diseases in Delhi
New Delhi: The national capital recorded 9,211 deaths due to respiratory diseases in 2024, up from 8,801 in 2023, continuing an upward trend seen over the past few years, according…
DoP calls for proposals to set up common facilities for medical device clusters
New Delhi: The Department of Pharmaceuticals (DoP) has invited applications from eligible stakeholders to set up common facilities for medical device clusters in the country, under the scheme for Strengthening…
47 Himachal-made medicines fail quality tests, companies asked to recall stock
These samples were part of a larger batch of 200 drugs tested nationwide that were found to be below standard, prompting the Central Drugs Standard Control Organisation (CDSCO) to issue…
‘Pharma companies need to look beyond US market’
HYDERABAD: With the Trump administration’s flip-flops on tariffs giving the Indian pharma industry a headache, experts feel it’s time the sector looked at an ‘America plus’ strategy to reduce heavy…
Pharma assns demand setting up of NIPER in silk city
Berhampur: Several pharmacist associations staged a rally on Monday and submitted a memorandum to Prime Minister Narendra Modi and chief minister Mohan Charan Majhi through the revenue divisional commissioner (south)…
Indian Pharma Poised To Gain As US Tariffs Impact Global Rivals: JP Morgan Report
Mumbai: Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report. Essentially, Indian pharmaceutical companies have the potential…
‘In Reality, Clinical Trials Conducted In Poorer Countries’ : Supreme Court In PIL Against Multinational Pharma Companies
In a PIL raising the issue of multinational pharmaceutical companies picking up poor people in India as “guinea pigs” for clinical drug trials, the Union informed the Supreme Court today…
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024
India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…
